BrahMos WORLD INDIA MADHYA PRADESH BHOPAL WTN SPECIAL GOSSIP CORNER RELIGION SPORTS BUSINESS FUN FACTS ENTERTAINMENT LIFESTYLE TRAVEL ART & LITERATURE SCIENCE & TECHNOLOGY HEALTH EDUCATION DIASPORA OPINION & INTERVIEW RECIPES DRINKS BIG MEMSAAB 2017 BUDGET 2017 FUNNY VIDEOS VIRAL ON WEB PICTURE STORIES Mahakal Ke Darshan
WTN HINDI ABOUT US PRIVACY POLICY SITEMAP CONTACT US
logo
Breaking News

Vitamin D supplements do not boost bone health: Lancet

Friday - October 5, 2018 5:02 pm , Category : HEALTH


Intake of Vitamin D supplements does not prevent fractures or falls or improve bone mineral density in adults especially in women claimed a new Lancet study.

Vitamin D supplements have long been recommended for older people to treat or prevent osteoporosis -- a bone loss condition -- with some early evidence suggesting benefits for bone health.
However the study published in The Lancet Diabetes and Endocrinology journal found no clinically meaningful effect of vitamin D supplementation on total fracture hip fracture or falls.

There was reliable evidence that vitamin D does not reduce total fractures hip fractures or falls by 15 per cent -- a clinically meaningful threshold.


Even when lower thresholds were assessed there was still reliable evidence that vitamin D does not reduce falls by 7.5 per cent and total fractures by 5 per cent, differences in the effects of higher versus lower doses of vitamin D.

"Our analysis finds that vitamin D does not prevent fractures falls or improve bone mineral density whether at high or low dose. Clinical guidelines should be changed to reflect these findings “said lead author Mark J. Bolland from the University of Auckland in New Zealand. "On the strength of existing evidence we believe there is little justification for more trials of vitamin D supplements looking at musculoskeletal outcomes” Bolland added.

In the study the team pooled data from 81 randomised controlled trials. Most included women aged over the age of 65 (77 per cent of trials) who lived in the community and who received daily doses of more than 800 IU per day (68 per cent of trials).

- IANS

 
Leave a Comment
* Name
* Email (will not be published)
*
* - Required fields